STIL and adrenal cortex carcinoma: In multiple cancers (including ACC, BLCA, KICH, KIRC, KIRP, LGG, LIHC, LUAD, MESO, PAAD, PRAD, SARC, PCPG, THCA, UCEC, and UVM), an increase of STIL expression was a risky factor for overall survival (OS) or recurrence-free survival (RFS) of cancer patients (Supplementary Table S2).